^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ensituximab (NEO-102)

    i
    Other names: NEO-102, NEO 101, NEO101, NPC 1C, NPC-1C, NPC1-C, NEO-101
    Associations
    News
    Trials
    Company:
    Precision Biologics
    Drug class:
    Neoplasm antigen inhibitor
    Associations
    News
    Trials